New Journey Health Technology Group Co.,LTD
002219.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.28B
Close$
$0.34
82.7% downside
Current Fair Value
82.7% downsideOvervalued by 82.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.28 Billion |
|---|---|
| Enterprise Value | $9.57 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.01 |
| Beta | 0.32 |
| Outstanding Shares | 3,451,921,753 |
Return
| Return on Equity | 1.51% |
|---|---|
| Return on Assets | 0.45% |
| Return on Invested Capital | 6.71% |
Valuation & Multiples
| P/E Ratio | 208.91 |
|---|---|
| PEG | -548.82 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.33 |
| Enterprise Value to EBIT | 45.33 |
| Enterprise Value to Net Income | 320 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | 1.34 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About New Journey Health Technology Group Co.,LTD
9,112 employees
CEO: Liu Jun This company maintains a diverse business portfolio, encompassing the provision of medical services, pharmaceutical manufacturing, and the distribution of daily chemical and wellness products. Its pharmaceutical production includes vario...